Invention Grant
- Patent Title: Cell-penetrating compstatin analogs and uses thereof
-
Application No.: US17126367Application Date: 2020-12-18
-
Publication No.: US11407789B2Publication Date: 2022-08-09
- Inventor: Cedric Francois , Pascal Deschatelets , Monica Gerber
- Applicant: Apellis Pharmaceuticals, Inc.
- Applicant Address: US MA Waltham
- Assignee: Apellis Pharmaceuticals, Inc.
- Current Assignee: Apellis Pharmaceuticals, Inc.
- Current Assignee Address: US MA Waltham
- Agency: Choate, Hall & Stewart LLP
- Agent Rolando Medina; Melissa M. Adams
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A61K38/12 ; C07K7/64 ; C07K7/08 ; C07K14/47 ; A61K47/64 ; C07K14/005 ; C07K14/475 ; C12N7/00 ; G01N33/564
Abstract:
In some aspects, the present invention cell-penetrating compstatin analog and compositions comprising cell-penetrating compstatin analog. In some aspects, the invention further provides methods of using cell-penetrating compstatin analogs treat a complement-mediated disorder, e.g., to inhibit complement-mediated damage to a cell, tissue, or organ, to inhibit production or release of biologically active C3 cleavage products.
Public/Granted literature
- US20210198320A1 CELL-PENETRATING COMPSTATIN ANALOGS AND USES THEREOF Public/Granted day:2021-07-01
Information query
IPC分类:
